MaxiVision Eye Hospitals have announced their expansion plans to Tamil Nadu and Karnataka. With over 27 years of stellar practice in the states of Andhra and Telangana, the group is the first choice of quality eye care with superior technology, for the population of these two states.

Dr GSK Velu, Chairman, MaxiVision Eye Hospitals said, “The expansion plan was set back for a while bidding for Vasan Eye Care, which the company has withdrawn due to various reasons. We are starting with one super specialty eye hospital in Tiruchirappalli, and expanding to other districts of Tamil Nadu within the next six months. We are fortunate to have the leadership of Dr Shibu Varkey, a leading ophthalmologist in Chennai, with over 25 years of experience and performed over a lakh of surgeries. Dr Varkey, as Regional Medical Director, along with his team of eight other surgeons, and experienced management professionals will head the Trichy Cluster, which will spearhead our aggressive expansion plans in entire Tamil Nadu. In phase two, we will enter Karnataka, and Kerala, along with our organic expansion in other districts of Andhra Pradesh and Telangana."
 
Sudheer, Group CEO, MaxiVision Eye Hospitals, said “MaxiVision will set up Super Specialty Tertiary care eye hospitals, in potential districts of Trichy, Salem, Madurai, Coimbatore, and Chennai, as hub centres supported by spoke secondary care eye hospitals, around these hubs in Tanjore, Kumbakonam, Perambalur, Erode, Namakkal, Dharmapuri, Tuticorin, Tiruppur, Pollachi, Vellore, and Hosur, within this year. In the year 2023, we will also start our first hospital in Karnataka, in Bengaluru. The aggressive expansion plan will add 14 hospitals next year to the group, led by a team of 48 doctors and around 1000 patient care teams to give exemplary patient care in these hospitals. We are also in the process of engaging key doctors in Bangalore and other potential districts of Karnataka, along with districts in North Kerala, with senior surgeons to head the hospitals in these states."